(Q50777922)

19 March 2018

title

Clinical, epidemiological and outcome features of patients with cryptococcosis in Uberaba, Minas Gerais, Brazil. (English)

1 reference

19 March 2018

1 reference

0 references

3

1 reference

19 March 2018

author name string

Delio José Mora

1

1 reference

19 March 2018

Eduardo Rodrigues da Cunha Colombo

2

1 reference

19 March 2018

Leonardo Eurípedes Andrade-Silva

4

1 reference

19 March 2018

Gabriel Antonio Nogueira Nascentes

5

1 reference

19 March 2018

Mario León Silva-Vergara

6

1 reference

19 March 2018

publication date

1 December 2011

1 reference

19 March 2018

number of pages

7

1 reference

inferred from page(s)

published in

Mycopathologia

1 reference

19 March 2018

volume

173

1 reference

19 March 2018

issue

5-6

1 reference

19 March 2018

page(s)

321-327

1 reference

19 March 2018

https://scigraph.springernature.com/pub.10.1007/s11046-011-9504-9

exact match

0 references

cites work

HIV-associated cryptococcal meningitis.

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

Central nervous system involvement in cryptococcal infection in individuals after solid organ transplantation or with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

Cryptococcosis in the developing world: an elephant in the parlor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

In-hospital mortality of HIV-infected cryptococcal meningitis patients with C. gattii and C. neoformans infection in Gaborone, Botswana

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

The Outbreak of Cryptococcus gattii in Western North America: Epidemiology and Clinical Issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

Cryptococcus gattii genotype VGIIa infection in man, Japan, 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

Communicating the risks of a new, emerging pathogen: the case of Cryptococcus gattii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

Cryptococcosis: a review of the Brazilian experience for the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

Low CD4 count plus coma predicts cryptococcal meningitis in Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

The spectrum of computerized tomography (CT) findings in central nervous system (CNS) infection due to Cryptococcus neoformans var. gattii in immunocompetent children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

Regional pattern of the molecular types of Cryptococcus neoformans and Cryptococcus gattii in Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

Cryptococcus neoformans var. gattii in a Brazilian AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

Clinical and epidemiological features of 123 cases of cryptococcosis in Mato Grosso do Sul, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

Risk factors for Cryptococcus gattii infection, British Columbia, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

Cryptococcus gattii infection: characteristics and epidemiology of cases identified in a South African province with high HIV seroprevalence, 2002-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

Cryptococcus gattii in AIDS patients, southern California

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

Prevalence of clinical isolates of Cryptococcus gattii serotype C among patients with AIDS in Sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

Primary endemic Cryptococcosis gattii by molecular type VGII in the state of Pará, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

Declining number of patients with cryptococcosis in the Netherlands in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11046-011-9504-9

[AIDS-associated meningeal cryptococcosis in the Hospital Diego Paroissien from 1996-1999]

21 January 2018

1 reference

12 December 2020

Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy

1 reference

12 December 2020

Central nervous system infections in patients with systemic lupus erythematosus.

1 reference

12 December 2020

Cryptococcus gattii: An Emerging Cause of Fungal Disease in North America

1 reference

12 December 2020

1 reference

12 December 2020

Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C).

1 reference

12 December 2020

1 reference

12 December 2020

The clinical laboratory characteristics of 104 cases of cryptococcal meningoencephalitis

1 reference

12 December 2020

Molecular analysis of 311 Cryptococcus neoformans isolates from a 30-month ECMM survey of cryptococcosis in Europe

1 reference

12 December 2020

Cryptococcosis due to Cryptococcus neoformans var. gattii in Brazilian patients with AIDS. Report of three cases

1 reference

12 December 2020

10.1007/S11046-011-9504-9

Identifiers

DOI

1 reference

19 March 2018

1 reference

19 March 2018